Novel antifungals set for market introduction
Interviewee/Contributor
Peter Charlish
Organisation
MedNous
Drug discovery
Live biotherapeutics change the pharma landscape
Interviewee/Contributor
Duncan Peyton
Organisation
4D pharma Plc
ASCO 2021- Oncology developers disclose their latest data
Interviewee/Contributor
Victoria English
Organisation
MedNous
Insect-derived peptides - next generation antibiotics?
Interviewee/Contributor
Moshik Cohen-Kutner and Niv Bachnoff
Organisation
Omnix Medical
Phosphatases rise from the ashes
Interviewee/Contributor
Gerhard Müller
Organisation
Anavo Therapeutics BV
A new strategy for regenerating damaged tissue
Interviewee/Contributor
Tim Knotnerus
Organisation
AgomAb Therapeutics NV
Leyden Labs plans to protect against viral infections
Interviewee/Contributor
Koenraad Wiedhaup
Organisation
Leyden Laboratories BV
Taming food-induced immune disorders
Interviewee/Contributor
Poul Sørensen
Organisation
Allero Therapeutics BV
Developing radionuclide PARP inhibitors
Interviewee/Contributor
Greg Mullen
Organisation
Theragnostics Ltd
The linker matters in antibody-drug conjugates
Interviewee/Contributor
Philipp Spycher
Organisation
Araris Biotech AG